PALISADE BIO, INC. (PALI) Cash Flow Statement
PALISADE BIO, INC. (PALI) generated -$18.2M of operating cash flow over the twelve months to 2026-06-30, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PALIPALISADE BIO, INC.Follow PALI — free
—
Price chart with a free account
- Market cap
- 231.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -8.1 | -8.5 | -10.6 | -11.7 | -18.9 | -15.6 | -13.4 | -7.7 | -7.3 | -4.8 | -14.8 | -13.4 | -11.1 | -12.2 | -10.8 | -18.2 | |
| Capital expenditure | 0.2 | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Free cash flow | -8.3 | -8.5 | -10.7 | -11.9 | -19.1 | -15.7 | -13.4 | -7.7 | — | -4.8 | -14.8 | -13.4 | -11.1 | -12.2 | — | — | |
| Stock-based compensation | 3.3 | 1.6 | 2.3 | 4.3 | 3.0 | 3.4 | 1.8 | 0.6 | 0.9 | 2.0 | 1.9 | 1.0 | 0.6 | 0.7 | 4.0 | — |
USD millions · SEC XBRL
PALISADE BIO, INC. — questions
- What is PALISADE BIO, INC.'s operating cash flow?
- -$18.2M over the twelve months to 2026-06-30.
Every figure on this page comes from PALISADE BIO, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.